Navigating Swiss Market Access #medtech #digitalhealth

• Episode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland?

  In this episode, we explore the reimbursement landscape for digital health technologies (DHTs) in Switzerland with Angelina, offering an introductory overview of key pathways to market access.We focus on the inclusion of DHTs in Switzerland’s compulsory health insurance system ("OKP") and touch on the essential reimbursement criteria—known as the "EAE criteria" or "WZW-Kriterien":Effectiveness (Wirksamkeit)Appropriateness (Zweckmässigkeit)Cost-effectiveness (Wirtschaftlichkeit)We also highlight practical challenges, identify useful public resources and documentation from the Swiss Federal Office of Public Health (FOPH/BAG), and discuss what innovators should consider when navigating the Swiss healthcare system.This episode is ideal for developers, investors, and stakeholders interested in bringing digital solutions to the Swiss market.Future episodes will offer a deeper dive into the regulatory requirements associated with the EAE criteria for securing reimbursement under the compulsory health insurance system.GET IN TOUCH: Feedback? We’re listening. Send us a message on LinkedIn: https://linkedin.com/in/gurmitsandhu | https://linkedin.com/in/angelina-rau Share your experience, feedback, “pain points” or success with market access & reimbursement of digital health technology #medtech # #meddevice : on the comments section below or DM us on LinkedIn Do you know someone who would be a great guest for us to interview? Let us know via LinkedIn | Topics that you want us to focus on. Drop us a comment below! What to Read: Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>https://swisshealthcarestartups.com/en/reimbursement-guide Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023 Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies For...

  --------  

  12:15
• Episode 1 Introducing the Value Assessment Dashboard (VAD) with Gurmit

  In this debut episode, Gurmit presents his Value Assessment Dashboard (VAD)—a comprehensive tool designed to evaluate digital health technologies across seven key value domains. The VAD helps determine a technology’s potential for reimbursement, market access, and adoption, bridging the gap between innovation and patient access to better healthcare.Developed as part of Gurmit’s MSc Medical Informatics research thesis, the VAD is built upon prior consultancy work in co-developing an orientation guide for assessing digital health technologies (1).The framework serves multiple stakeholders, including startups, insurance companies, hospitals, governments, and health technology assessment (HTA) agencies.🔹 Assessment Framework: The VAD consists of seven value domains (not prioritized) and 26 subdomains, covering: ✔️ Unmet medical need & current technology use ✔️ Technical product information & use ✔️ Usability & accessibility ✔️ Safety ✔️ Effectiveness ✔️ Cost impact ✔️ Ethical aspects 🔹 International Efforts & Contextualization for Switzerland :Switzerland currently assesses health technologies (including medical services and pharmaceuticals) using established frameworks (EAE/WZW). However, some Swiss digital health stakeholders recognize that digital health technologies may require tailored evaluation frameworks.The VAD received validation at the 2024 Health Technology International (HTAI) Conference in Seville, where Gurmit engaged with experts working on assessment frameworks for digital health from Catalunya, Denmark, and Italy.Some early adopter insurance companies are exploring the application of HTA-based frameworks for their internal evaluation of digital health solutions.The ultimate goal of the Value Assessment Dashboard is to ensure that promising digital health technologies reach patients by applying rigorous, transparent scientific and quality measures to the evaluation process.In our next episode, we’ll dive into Angelina’s work as an Attorney at Law in market access and her PhD research on reimbursement of DTx.(1) C/CAN. (2023).  Adopting digital health interventions in LMICs. Guidance for value assessment.   City Cancer Challenge.  https://citycGET IN TOUCH: Feedback? We’re listening. Send us a message on LinkedIn: https://linkedin.com/in/gurmitsandhu | https://linkedin.com/in/angelina-rau Share your experience, feedback, “pain points” or success with market access & reimbursement of digital health technology #medtech # #meddevice : on the comments section below or DM us on LinkedIn Do you know someone who would be a great guest for us to interview? Let us know via LinkedIn | Topics that you want us to focus on. Drop us a comment below! What to Read: Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>https://swisshealthcarestartups.com/en/reimbursement-guide Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023 Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies For...

  --------  

  11:39
• Meet your co-hosts & their why | Increasing your confidence on #healthtech market acces

  We will be exploring, developing a better understanding, and uncovering strategies & tactics to enhance Swiss market access (reimbursement) for digital health technologies (DHTs), including MedTech and Medical Devices. With our combined expertise in digital health technologies, we’ll invite key stakeholders to share their insights, where we will: a. discuss their challenges, opportunities, and successes in the Swiss market access ecosystem.b. delve into their pain points, constraints, and innovative solutions shaping the future. What you'll gain from listening to our podcast on Swiss Market Access:Valuable insights into Swiss regulations and guidance on digital health technologies.A deeper understanding of decision-making and strategic planning in Switzerland. Greater confidence navigating the Swiss digital health industry—an emerging market.Our listeners like you, who are digital health leaders & innovators. Especially Swiss-based or focused:Industry:  payers & insurance companies, commercial manufacturers, tech providers, and medtech associations.Health Startups: including software developers & engineers.National component agencies including regulatory and/or those conducting value assessments on digital health technologies.Clinical: clinicians, healthcare professionals, and hospital administrators.Patients & Advocates: patients, organizations, and patient leaders. Ethicists.Academic & Research: researchers, academics, & digital biomarkers researchers.Innovation Centres:  digital health hubs and Innovation and education-focused groups.And those interested in launching their digital health technologies in Switzerland.If you are one or more of the above stakeholders but are too busy to read & process updates on market access (reimbursement) considerations on digital health technologies in Switzerland, then you are our listener. Subscribe & give our podcast a listen! Upcoming Monthly Episodes:Gurmit discusses with Angelina his research journey on the dashboard on the value assessment of digital health technologies. When presenting at HTAi conference, it validated the relevance of his research.Angelina discusses with Gurmit her experiences as a lawyer working in life sciences, particularly on Swiss market acceGET IN TOUCH: Feedback? We’re listening. Send us a message on LinkedIn: https://linkedin.com/in/gurmitsandhu | https://linkedin.com/in/angelina-rau Share your experience, feedback, “pain points” or success with market access & reimbursement of digital health technology #medtech # #meddevice : on the comments section below or DM us on LinkedIn Do you know someone who would be a great guest for us to interview? Let us know via LinkedIn | Topics that you want us to focus on. Drop us a comment below! What to Read: Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>https://swisshealthcarestartups.com/en/reimbursement-guide Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023 Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies For...

  --------  

  3:07

Meer Technologie podcasts

Trending Technologie -podcasts

Over Navigating Swiss Market Access #medtech #digitalhealth